#002 ·19 JUN 2026 ·FRIDAY ·5 MIN READ ·10 STORIES + 12 EXTRAS

The Map, the Clock, and the Shot

The longevity field got its three missing infrastructure pieces in a single week: a senescent-cell atlas (the map), an RCT proving semaglutide slows the biological aging pace (the clock), and a gene therapy extending old-mouse lifespan by a fifth with a single injection (the shot). The bottom line: the field is transitioning from cataloguing the hallmarks of aging to intervening on them, and for the first time, human data and animal data are converging on the same targets.

01 / The Ten

The week, ranked

Semaglutide slows epigenetic aging pace by 9% in RCT

A randomized, double-blind, placebo-controlled trial from UC San Diego found semaglutide reduced the DunedinPACE epigenetic aging clock score by 9% — the first placebo-controlled human evidence that a GLP-1 agonist measurably slows the biological rate of aging, not just its metabolic consequences.

Why it mattersMoving GLP-1 effects from weight-adjacent to directly geroprotective is a meaningful mechanistic step, and the RCT design is stronger than the observational work that preceded it.

01 nature.com↗

NIH SenNet publishes first atlas of senescent cells across human tissues

The Cellular Senescence Network consortium published a compendium in Cell, delivering the first systematic map of senescent cells across human tissues alongside new computational tools and blood biomarkers predicting age-related health risks.

Why it mattersAn atlas-level reference is the prerequisite for moving senescence research from mechanism to targeted therapy — the equivalent of the Human Genome Project for cellular aging.

02 cell.com↗

Single FGF21 gene therapy shot extends aged-mouse lifespan by 20%

Researchers at UAB Barcelona delivered a single AAV vector encoding FGF21 to skeletal muscle of old mice, producing a 20.5% lifespan extension with normalized weight, improved insulin sensitivity, and enhanced mitochondrial function — without reducing food intake.

Why it mattersA one-time treatment with durable multi-organ metabolic effects in geriatric animals is a harder test than most rodent longevity studies attempt.

03 lifespan.io↗

Rare cGAS variants in long-lived families delay disease onset 13 years

Leiden University researchers identified 12 rare genetic variants including a cGAS mutation found independently in two long-lived families; carriers showed a 13-year delay in chronic disease onset, apparently by suppressing chronic inflammation.

Why it mattersA naturally occurring mutation that extends healthy lifespan by dampening inflammaging provides a high-confidence genetic target for therapeutic cGAS-STING pathway modulation.

04 biorxiv.org↗

DDX1-XPO1 R-loop export drives inflammaging — blocking it extends healthspan

A Nature Aging paper identifies a two-protein complex that shuttles R-loops out of the nucleus during senescence, triggering cGAS-STING and fueling inflammaging. Blocking XPO1 with FDA-approved selinexor reduced age-associated inflammation and extended lifespan in preclinical models.

Why it mattersAn already-approved drug targeting a specific nuclear export mechanism in the cGAS-STING pathway is a druggable, fast-translatable target.

05 nature.com↗

Cambrian Bio ATX-304 shows positive Phase 1b metabolic data

Cambrian Bio's AMPK network activator ATX-304 produced significant reductions in liver fat, visceral adipose tissue, and triglycerides in adults with obesity and prediabetes, with resting metabolic rate and adiponectin also improving.

Why it mattersPhase 1b human data for a purported exercise-mimetic in a cardiometabolic population represents a concrete clinical step beyond the largely preclinical longevity drug landscape.

06 statnews.com↗

Life Biosciences doses first human with reprogramming therapy

Life Biosciences administered ER-100 — a cellular reprogramming injection targeting glaucoma — to its first human participant, marking the first-in-human milestone for direct ocular reprogramming.

Why it mattersThe eye is chosen because adverse events are more contained than systemic administration; success opens a path toward broader tissue reprogramming trials.

07 lifebiosciences.com↗

NewLimit raises $435M Series C for epigenetic reprogramming

NewLimit closed a $435M Series C to advance its platform targeting partial cell rejuvenation by modifying methylation patterns in aged cells without reverting them to pluripotency.

Why it mattersThe round size places NewLimit among the best-funded longevity biotechs and reflects growing investor confidence that partial reprogramming can be made therapeutically safe.

08 fightaging.org↗

Damage accumulation model finds two distinct aging regimes across species

A mathematical framework in Nature Aging shows species split into two broad aging modes, with damage production rate — not repair capacity — as the single best predictor of maximum lifespan across the animal kingdom.

Why it mattersQuantifying cross-species aging into two regimes gives biologists and drug developers a cleaner theoretical target than the current sprawl of hallmarks.

09 nature.com↗

Antioxidants selectively clear senescent cells via mTORC1

A study in Aging Cell found antioxidants reduce oxidative stress in senescent muscle cells, dampening mTORC1 hyperactivation and rendering those cells vulnerable to death under nutrient scarcity — while leaving healthy cells unaffected.

Why it mattersA mechanism by which a broad class of compounds selectively eliminates senescent cells without general cytotoxicity advances the practical case for targeted senolytic approaches.

10 lifespan.io↗

02 / Also

Worth knowing

Fragmented sleep rhythms linked to 2.5x higher dementia risk

Individuals with the most fragmented circadian rhythms had more than 2.5x the dementia risk — irregular timing rather than short duration.

n.neurology.org ↗

Shingrix recipients show 24% lower dementia risk over four years

Nursing home residents who received the recombinant shingles vaccine had 24% lower dementia incidence, adding to vaccine-dementia association literature.

statnews.com ↗

Childhood adversity accelerates biological age by up to 2.7 years

Adults who experienced forced displacement in childhood had biological ages 1.5–2.7 years ahead of peers, measured by DNA methylation clocks.

aging-us.com ↗

Calcium homeostasis drug extends aged-mouse lifespan by 17%

An existing approved compound improved multiple health parameters and extended median lifespan by 17% in aged mice via calcium metabolism and senescent cell modulation.

fightaging.org ↗

Centenarian-derived Lactobacillus strain cuts lung fibrosis in mice

A strain isolated from centenarians reduced pulmonary fibrosis in aged mice by boosting short-chain fatty acids and suppressing pro-fibrotic Th17 cells.

lifespan.io ↗

Machine-learning Liver Aging Index outperforms chronological age

A clinical biomarker-based liver aging clock predicted cirrhosis, liver cancer, and all-cause mortality more accurately than chronological age alone.

fightaging.org ↗

Resistance training sweet spot: 90–120 minutes per week

Analysis of 147,000 participants found maximum all-cause mortality benefit at 90–120 minutes weekly of resistance training, with diminishing returns beyond.

bjsm.bmj.com ↗

Phase 3 oral PCSK9 inhibitor cuts LDL by ~60%

Merck's enlicitide showed approximately 60% LDL reduction in 2,909 high-risk patients, with a safety profile comparable to existing statins.

merck.com ↗

Emergency blood cell production switch tied to aging and AML

A molecular switch governing emergency myelopoiesis, when stuck on, drives chronic inflammation linked to accelerated aging and acute myeloid leukemia.

cuimc.columbia.edu ↗

Higher blood tyrosine consistently linked to shorter male lifespan

Elevated circulating tyrosine was associated with approximately one year shorter life expectancy in men across 270,000+ individuals, with no comparable signal in women.

aging-us.com ↗

Mutation resistance in fibroblasts scales with species lifespan

Longer-lived species systematically exhibit stronger DNA repair capacity in fibroblast cells, establishing a direct cross-species correlation.

fightaging.org ↗

Metformin reverses primate intestinal aging marker

Single-nucleus sequencing in primate small intestine identified NCoR1 decline with age; metformin restored activity toward younger-animal levels.

nature.com ↗

Be subscriber #012 one email a week · no spam · unsubscribe anytime

Back issues

The Archive

#008The Clock Moves Both Ways #007Longer Lives, Sicker Decades #006The Clock Audit #005The pipeline got shorter #004The atlas drops #003Clocks, Clearance, and the Inflammation Problem #002The Map, the Clock, and the Shot #001Two Aging Regimes, One Primate Gut, and an Open Challenge

The Map, the Clock, and the Shot

The week, ranked

Semaglutide slows epigenetic aging pace by 9% in RCT

NIH SenNet publishes first atlas of senescent cells across human tissues

Single FGF21 gene therapy shot extends aged-mouse lifespan by 20%

Rare cGAS variants in long-lived families delay disease onset 13 years

DDX1-XPO1 R-loop export drives inflammaging — blocking it extends healthspan

Cambrian Bio ATX-304 shows positive Phase 1b metabolic data

Life Biosciences doses first human with reprogramming therapy

NewLimit raises $435M Series C for epigenetic reprogramming

Damage accumulation model finds two distinct aging regimes across species

Antioxidants selectively clear senescent cells via mTORC1

Worth knowing

The Archive

Get the brief